AGL - Company ID 0001831097
The table below shows agilon health, inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B | $1.22B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $238.54M |
agilon health, inc. reported annual revenue of $5.93B for fiscal year 2025. That is down 2.1% from $6.06B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $794.41M (FY 2019) to $5.93B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $268.91M |
| $285.76M |
| $207.79M |
| $427.50M |
| $137.29M |
| Operating income | -$463.24M | -$292.13M | -$232.13M | -$105.38M | -$372.24M | -$56.67M |
| Income tax | $1.25M | $1.45M | $791.00K | $1.64M | $886.00K | $865.00K |
| Net income | -$391.35M | -$260.15M | -$262.60M | -$106.55M | -$406.49M | -$60.05M |
| EPS (diluted) | - | - | - | - | - | - |